NCT04099641 2023-02-08An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer PatientsOncXerna Theraputics, Inc.Phase 2 Completed80 enrolled 14 charts
NCT01272791 2017-04-19Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic CancerPeregrine PharmaceuticalsPhase 2 Completed70 enrolled